14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ACHV vs PRPO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Achieve Life Sciences, Inc. (ACHV) captures the overall head-to-head institutional edge over Precipio, Inc. (PRPO) on higher Unified Composite conviction (56.6/100 HOLD vs. 32.2/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Options & Positioning), while PRPO wins 4–2 across the 6-pillar growth and valuation breakdown. ACHV trades at $6.78 (35.3x Forward P/E, 0.0% operating margin) versus PRPO at $20.35 (15.4x Forward P/E, -5.3% operating margin).
Growth vs. Quality Trade-Off: ACHV earns the overall head-to-head edge with a stronger Unified Composite Score (56.6/100 HOLD vs. PRPO 32.2/100 SELL) and 1.73β · 62% Vol risk profile, whereas PRPO leads top-line expansion (+8.3% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACHV vs PRPO. Trailing 12-month operating profitability (ACHV 0.0% vs PRPO -5.3%) and valuation multiples (ACHV 35.3x vs PRPO 15.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Diagnostics & Research value chain with $40.2M market capitalization and -5.3% operating margin.
OpEx & R&D Reinvestment49.9% of Rev ($14M)
90D Engineering Disclosures0 Published
Investor FAQ ACHV vs PRPO Key Questions & Quantitative Answers
As of Nov 16, 2026, Achieve Life Sciences, Inc. (ACHV) captures the overall head-to-head institutional edge over Precipio, Inc. (PRPO) on higher Unified Composite conviction (56.6/100 HOLD vs. 32.2/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Options & Positioning), while PRPO wins 4–2 across the 6-pillar growth and valuation breakdown. ACHV trades at $6.78 (35.3x Forward P/E, 0.0% operating margin) versus PRPO at $20.35 (15.4x Forward P/E, -5.3% operating margin). Growth vs. Quality Trade-Off: ACHV earns the overall head-to-head edge with a stronger Unified Composite Score (56.6/100 HOLD vs. PRPO 32.2/100 SELL) and 1.73β · 62% Vol risk profile, whereas PRPO leads top-line expansion (+8.3% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
PRPO leads the Growth & Scale pillar: ACHV posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with PRPO at +8.3% YoY revenue growth and +0.0% YoY earnings growth on $28M TTM revenue (44.6% gross margin, -5.3% operating margin). On trailing 12-month operating scale, ACHV generates N/A in USD-normalized revenue versus $28M for PRPO. In operating R&D and SG&A reinvestment, ACHV deploys N/A (0 90-day corporate R&D disclosures) versus 49.9% of Rev ($14M) (0 disclosures) for PRPO.
PRPO screens cheaper on headline valuation multiples. ACHV trades at 35.3x Forward P/E, 35.3x Trailing P/E, 17.68x PEG, and N/M EV/Revenue (unreported FCF margin), whereas PRPO trades at 15.4x Forward P/E, 15.4x Trailing P/E, N/M PEG, and 1.4x EV/Revenue (-0.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACHV (-845.0% ROE) versus PRPO (-8.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ACHV carries 88.3% implied volatility (23rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (1.73β · 62% Vol realized risk). By comparison, PRPO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.21β · 96% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.